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Although screening rates for colorectal cancer are increasing, 22
million  Americans  are  not  up-to-date  with  recommendations.
People with diabetes are an important and rapidly growing group
at increased risk for colorectal cancer. Screening status and pre-
dictors of being up-to-date on screening are largely unknown in
this population.
Methods
This study used logistic regression modeling and data from the
2012 Behavioral Risk Factor Surveillance System to examine the
association between diabetes and colorectal cancer screening pre-
dictors with being up-to-date on colorectal cancer screening ac-
cording to criteria of the US Preventive Services Task Force for
adults  aged  50  or  older.  State  prevalence  rates  of  up-to-date
colorectal cancer screening were also calculated and mapped.
Results
The prevalence of being up-to-date with colorectal cancer screen-
ing for all respondents aged 50 or older was 65.6%; for respond-
ents with diabetes, the rate was 69.2%. Respondents with diabetes
were  22%  more  likely  to  be  up-to-date  on  colorectal  cancer
screening than those without diabetes. Among those with diabetes,
having a routine checkup within the previous year significantly in-
creased the odds of being up-to-date on colorectal cancer screen-
ing (odds ratio, 1.90). Other factors such as age, income, educa-
tion, race/ethnicity, insurance status, and history of cancer were
also associated with up-to-date status.
Conclusion
Regardless of diabetes status, people who had a routine checkup
within the past year were more likely to be up-to-date than people
who had not. Among people with diabetes, the duration between
routine checkups may be of greater importance than the frequency
of diabetes-related doctor visits. Continued efforts should be made
to ensure that routine care visits occur regularly to address the pre-
ventive health needs of patients with and patients without diabetes.
Introduction
Colorectal cancer (CRC) is the second leading cause of cancer-re-
lated death in the United States (1) and is positively associated
with type 2 diabetes (2) because of shared risk factors (1–3). Bio-
logic mechanisms may also increase CRC risk for people with dia-
betes (1–3), possibly because increased exposure of colonic mu-
cosa  to  carcinogens  caused  by  slower  bowel  transit  times  in-
creases fecal bile acids associated with blood glucose and trigly-
cerides (1).
Treatment  of  age-appropriate,  screening-detected  polyps  and
early-stage cancer reduces CRC incidence and mortality: the 5-
year CRC survival rate is approximately 90% when CRC is found
early and treated (4,5). Approximately 22 million Americans are
not up-to-date with CRC screening (6). According to the US Pre-
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ventive Services Task Force (USPSTF) and the American Cancer
Society (ACS), a person is up-to-date on CRC screening if he or
she has had a fecal occult blood test (FOBT) within the past year,
a sigmoidoscopy within the past 5 years and an FOBT within the
past 3 years, or a colonoscopy within the past 10 years (4). USP-
STF and ACS recommendations differ by age: USPSTF recom-
mends screening for both men and women aged 50 to 75, but ACS
does not recommend stopping at age 75 (3,4).
Data on rates of cancer screening by diabetes status are not definit-
ive (7–11). One study found that women with diabetes aged 67
years or older were less likely (odds ratio, 0.79) than same-aged
women without diabetes to receive CRC screening (8). This study
also found that higher screening rates were associated with in-
creasing numbers of physician visits and diabetes preventive ser-
vices (8). Other researchers found that people with chronic dis-
eases (12–14) are frequently underscreened (8–12) despite more
health care visits.
We examined the association between self-reported diabetes and
being up-to-date on CRC screening and predictors of being up-to-
date on CRC screening among adults aged 50 or older years over-
all and by diabetes status.
Methods
Survey design
We conducted analyses using 2012 Behavioral Risk Factor Sur-
veillance System (BRFSS) data (15). We limited the study popula-
tion to respondents aged 50 years or older; respondents younger
than 50 years are not asked questions about their CRC screening
behavior, because they do not meet the screening age recommen-
ded by USPSTF or ACS.
Respondents with a history of colon or rectal  cancer were ex-
cluded; because they are at increased risk of CRC, the screening
guidelines for people of average risk do not apply to them (16).
Established in 1984, the BRFSS is the world’s largest continu-
ously conducted health survey system; it is a cross-sectional, ran-
dom-digit–dial telephone (landline and cell) survey of noninstitu-
tionalized US adults on health-related behaviors, chronic health
conditions, and use of preventive services (17). This study was ap-
proved by the University of South Carolina’s institutional review
board.
Variables
The outcome of interest was being up-to-date on CRC screening
based on the latest USPSTF criteria (4). BRFSS respondents were
given a brief description of each screening test and then asked
whether they ever had any of them. If they responded yes for any
test, they were asked how long it had been since their last one. We
used these responses to calculate a composite variable represent-
ing a bivariate up-to-date screening status.
Self-reported diabetes status was the main exposure of interest and
was measured by using the question “Have you ever been told by
a physician that you have diabetes?” We categorized respondents
who answered yes as having diabetes, and we excluded women
who responded “yes, but told only during pregnancy” from ana-
lyses.
A comorbidity score was calculated by using a summary score
based on the self-report of 4 conditions (heart attack, angina or
coronary heart disease, stroke, or asthma) from a series of 4 ques-
tions: “Have you ever been told by a physician that you have [co-
morbidity]?” Those who responded yes to a comorbidity were giv-
en a score of 1 for that question; the comorbidity score had a range
of 0 to 4, depending on the number of comorbidities reported.
We categorized respondents who answered no or “no, pre-dia-
betes or borderline diabetes” as not having diabetes. Both type 1
and type 2 diabetes are included in this question because BRFSS
does not ask respondents to make this differentiation. Demograph-
ic covariates included age (50–69 y, ≥70 y), sex (female, male),
race/ethnicity (white non-Hispanic,  nonwhite [including white
Hispanic]),  marital  status  (married  or  one  of  a  couple,  not
married), education level (high school graduate or less, at least
some  college)  and  annual  household  income  (<$35,000,
≥$35,000). Other covariates of interest included body mass index
(BMI in kg/m2 calculated from self-reported height and weight),
general health status, exercise in the past 30 days, health insur-
ance  coverage,  length  of  time  since  the  most  recent  routine
checkup, number of visits in the past year for diabetes care, co-
morbidity score, and history of cancer; these questions have been
detailed elsewhere (18). Respondents who reported having dia-
betes also reported the number of times in the past year they had
seen a health professional for their diabetes. Selection of covari-
ates was based on reports in scientific literature (8,11,19,20).
Statistical analyses
We analyzed data using SAS Version 9.4 (21). We used weighted
SAS survey procedures for all analyses because of the complex
survey design of BRFSS. We used univariate analyses to determ-
ine the relationship of the covariates with the outcome. We used
multivariable logistic regression to examine the relationship of
diabetes and being up-to-date on CRC screening, adjusting for
age, sex, race/ethnicity, income, education, health insurance status,
marital status, BMI, physical activity, history of cancer, time since
most recent routine checkup, and comorbidity score (Model 1). To
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determine the final multivariable logistic regression model, we
used model selection procedures using manual backward elimina-
tion with a cutoff of P < .10 for regression coefficients. Variables
with P > .10 were not included in the final multivariable models.
We examined interactions between diabetes and the other covari-
ates; we included interactions significant at P < .05 in the mul-
tivariable logistic regression model.
We analyzed data on the subset of respondents with diabetes. We
used the same model selection procedures for the multivariable lo-
gistic regression model for respondents with diabetes (Model 2)
that we used in Model 1; we did not examine interactions, be-
cause the main variable of interest in interaction testing was dia-
betes status.
Multivariable  logistic  regression  examined  the  relationship
between covariates and being up-to-date on CRC screening among
respondents with diabetes (adjusting for age, sex, income, educa-
tion, health insurance status, marital status, BMI, physical activity,
health status, history of cancer, time since most recent routine
checkup, comorbidity score, and number of diabetes-related visits
in past  year).  In a  post-hoc analysis,  we analyzed whether  re-
spondents with diabetes were more likely or less likely than re-
spondents without diabetes to use colonoscopy (or FOBT) for
CRC screening. Finally, we developed choropleth maps depicting
the state prevalence of adults aged 50 or older being up-to-date on
CRC screening using ArcGIS Version 10.1 (22).
Results
We included data on 258,448 respondents (unweighted) in the
analytic sample. Overall, the majority of respondents were wo-
men (51.5%), were aged 50 to 69 years (71.9%), were white non-
Hispanic  (73.8%),  had  annual  household  income greater  than
$35,000 (49.9%), completed some college (54.5%), were married
or one of a couple (61.8%), were overweight or obese (68.7%),
and had exercised in the past 30 days (71.5%) (Table 1). Approx-
imately 3 of  4  respondents  reported having a  routine checkup
within the past  year (78.4%), reported being in good or better
health (75.4%), had no comorbidities (80.0%), and reported hav-
ing some form of health coverage (89.9%); 11.3% reported a his-
tory of cancer other than CRC. Approximately 1 of 6 respondents
reported having diabetes (18.8%).
The characteristics of respondents with diabetes were similar to
those of the overall population for sex, income, education, and
marital  status.  However,  respondents with diabetes were more
likely to be older (≥70 y, 34.1% vs 28.1%), nonwhite (36.9% vs
26.2%), and overweight or obese (84.0% vs 68.7%); and more
likely to report not having exercised in the past 30 days (39.5% vs
28.5%), fair to poor health (48.0% vs 24.6%), and having a routine
checkup within the past year (88.2% vs 78.4%).The average num-
ber of doctor visits for diabetes care in the past year was 3.5 visits;
31.8% of respondents had 0, 1, or 2 diabetes care visits, and 47.2%
had 3 to 6 diabetes care visits. Comorbidities were more prevalent
among respondents with diabetes than among those in the overall
sample population (Table 1).
The prevalence of reported up-to-date CRC screening was 65.6%
for all respondents and 69.2% among respondents with diabetes
(Table 1). The prevalence of being up-to-date differed by state; we
found higher rates in the Northeast than in Alaska, the Southwest,
and the Midwest (Figure). Alaska had the lowest overall preval-
ence of being up-to-date (56.3%), whereas Massachusetts had the
highest overall prevalence (75.5%). In some states, the prevalence
of being up-to-date was higher among respondents with diabetes
than among those in the overall sample. For example, the preval-
ence of being up-to-date in Alaska’s overall population was 56.3%
and among respondents with diabetes, it was 72.5%. This differ-
ence was nearly 10 percentage points in Delaware, Idaho, Louisi-
ana, and Nevada. In contrast, the prevalence of being up-to-date
was lower among respondents with diabetes than among those in
the overall sample in Connecticut, the District of Columbia, and
South Dakota (Figure).
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Figure. Prevalence of up-to-date colorectal cancer screening among A) adults
aged 50 years or older and B) adults aged 50 years or older with diabetes,
Behavioral Risk Factor Surveillance System (BRFSS), 2012.
 
For the overall population, univariate analyses showed that all
variables were strongly associated with being up-to-date on CRC
screening (P < .05). Respondents with diabetes had approximately
22% greater odds of being up-to-date than respondents without
diabetes (Table 2). The multivariable logistic regression model
(Model  1)  showed  that  the  odds  of  being  up-to-date  on  CRC
screening varied by diabetes status and by time since most recent
routine checkup. Among those who had not had a routine checkup
within the past year, respondents with diabetes were more likely to
be up-to-date than respondents without diabetes (odds ratio [OR],
1.70). Respondents with diabetes who had a routine checkup with-
in the past year were nearly twice as likely to be up-to-date as re-
spondents with diabetes who had not had a routine checkup with-
in the past year (OR, 1.90). In the general population, other pre-
dictors of being up-to-date on CRC screening included older age,
higher income, higher BMI, being physically active, having 1 to 3
comorbidities (vs none), female sex, and history of cancer (Table
2). A race/ethnicity other than non-Hispanic white, being unin-
sured, having fair or poor health, and single marital status signific-
antly decreased the odds of being up-to-date on screening. We
found similar associations in the model for respondents with dia-
betes (Model 2). The number of diabetes-related visits in the past
year was not significantly associated with up-to-date CRC screen-
ing after we adjusted for other covariates. Among respondents
with diabetes, having 4 self-reported comorbidities was associated
with decreased odds of screening, whereas having 1 to 3 self-re-
ported comorbidities increased the likelihood of being up-to-date.
In the post-hoc analysis, we found that compared with the general
population, respondents with diabetes were slightly less likely to
use colonoscopy (83.3% vs 84.2%) and more likely to use FOBT
(5.7% vs 4.2%). Most of the general US population, as well as re-
spondents with diabetes, used colonoscopy to screen for CRC.
Discussion
The prevalence of BRFSS respondents in 2012 who were up-to-
date on CRC screening was higher for those with diabetes than for
those in the general population nationally and in nearly all states.
Regardless  of  diabetes  status,  respondents  who  had  a  routine
checkup within the past year were more likely to be up-to-date
with CRC screening than respondents who had not. This finding
emphasizes the importance of a routine checkup for preventive
health care. However, among those who had not had a routine
checkup within the past year, respondents with diabetes were more
likely to be up-to-date than respondents without diabetes. Thus,
people with diabetes seem to be more likely to be up-to-date on
their CRC screening even if they have not had a recent routine
checkup. Our results agree with the results of studies reporting that
people with diabetes are as likely as, or more likely than, people
without diabetes to receive CRC screening (7,8,23,24). The in-
creased  probability  of  being  up-to-date  with  CRC  screening
guidelines may be due to increased contact between people with
diabetes and the medical system. Among people with diabetes, the
duration  between  routine  checkups  may  be  a  more  important
factor than the frequency of diabetes-related doctor visits.  We
found that when diabetes-related visits in the past year exceeded 7
visits, the patient had significantly decreased odds of being up-to-
date. However, this association was not significant after we adjus-
ted for other covariates. This finding is consistent with other find-
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ings showing that people with chronic diseases are underscreened,
despite more health care visits (7–9,19). A reason for these find-
ings may be that preventive services are discussed during routine
visits, rather than during diabetes-related visits; the diabetes spe-
cialist may defer preventive services such as cancer screenings to
the primary care provider, or if the patient sees a primary care
physician for his or her diabetes care, the physician might wait un-
til the patient’s next routine checkup to discuss CRC screening.
The recent adoption of the patient-centered medical home model
in improving the quality of diabetes care and comprehensively ad-
dressing the needs of chronically ill patients may have influenced
our findings (25). Additionally, in the era of widespread use of
electronic medical records (EMRs), primary care physicians and
diabetes care specialists could rely on EMR-based prompts to alert
them when patients are eligible (or due) for screening.
The differences in up-to-date status across states may be due to
various factors, including, but not limited to, compositional ef-
fects (eg, population age distribution and racial/ethnic mix), differ-
ences in geographic access to CRC screening providers or facilit-
ies (26), primary care shortages (27), area poverty (28–30), or
state factors, such as policies requiring CRC screening coverage
(31). Data sets with more geographic granularity and statistical
power may be able to tease out the effects of such factors. With
full implementation of the Affordable Care Act, state differences
may also be mitigated, as more people enroll in health insurance
plans that cover CRC screening as a preventive service without pa-
tient cost-sharing.
This study used data from the BRFSS, which has strengths and
limitations. BRFSS respondents self-reported their diabetes status,
and blood glucose levels were not measured, which may have led
to an overreporting of diabetes prevalence. However, using data
from the National Health and Nutrition Examination Survey, one
study reported a diabetes prevalence of 17.5% among people 45 to
64 years  and a  prevalence of  33.0% among those 65 or  older,
which is consistent with the prevalence of 18.8% among people 50
years or older found in our study (32). In addition, studies found
that  self-reported  diabetes  and  sociodemographic  data  in  the
BRFSS are valid and reliable (33,34). A study using data from
2007 found only minor differences in self-reported diabetes status
between the BRFSS and the 2 most commonly used population-
based health surveys in the United States, the National Health In-
terview Survey (NHIS) and the National Health and Nutrition Ex-
amination Survey (NHANES) (35). Thus, despite this potential
shortcoming, the BRFSS is considered one of the best tools to
monitor leading health indicators using population-based self-re-
ported data (35). Future studies should examine the relationship
between up-to-date CRC screening status and prediabetes and the
relationship between motivation and intent to get screened for
CRC among people with diabetes and people without diabetes, as
well as potential external influences on CRC screening adherence
among people with diabetes (eg, physician recommendation, geo-
graphic access to colonoscopy providers, state screening initiat-
ives or policies). Because studies documented nonstationarity in
predictors of CRC screening adherence in the general population
across US states (36,37), further research is also needed to exam-
ine differences in predictors of CRC screening adherence among
people with diabetes.
The prevalence of adults aged 50 or older who are up-to-date on
their CRC screening was 65.6%, well below the target of 80% set
by  the  National  Colorectal  Cancer  Roundtable  (38).  Because
people with diabetes are at an increased risk of developing CRC
(1), it is encouraging to observe higher screening rates for the pop-
ulation with diabetes (69.2% up-to-date nationally, and near 80%
in Delaware, New Hampshire, and Maine). Screening programs
need to continue targeting this population, especially in Alaska,
the Southwest, and Midwest, where the prevalence of people up-
to-date on CRC screening was lower than average. These study
findings may help inform health professionals designing and im-
plementing programs aimed at improving and maintaining high
rates of CRC screening uptake among people with diabetes who
are of the recommended age. Results from this study show that
among people with diabetes, having a routine checkup within the
past year is a strong predictor of being up-to-date; however, the
number of diabetes-related visits in the past year did not predict
being up-to-date. These findings suggest that diabetes-related vis-
its may represent a missed opportunity to discuss CRC screening,
especially given the greater risk of CRC among people with dia-
betes than among people without diabetes.
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Tables
Table 1. Sociodemographic Characteristics of Adults Aged ≥50, by Diabetes Status and Whether Up-to-Date on Colorectal Cancer
Screening, 2012 BRFSSa
Variable
Adults Aged ≥50 Adults Aged ≥50 With Diabetes
All Up-to-Dateb All Up-to-Dateb
Overall NA       65.6 18.8 69.2
Age, y
50–69 71.9       62.8 65.9 67.0
≥70 28.1       73.1 34.1 73.7
Sex
Male 48.5       64.5 50.8 68.9
Female 51.5       66.6 49.2 69.5
Race
Non-Hispanic white 73.8       67.7 63.1 71.4
Nonwhite 26.2       59.6 36.9 65.3
Annual household income, $
<35,000 36.2       57.8 48.3 64.2
≥35,000 49.9       71.1 37.9 75.5
Don’t know or refused to answer 13.9       65.8 13.8 68.5
Education
High school graduate or less 45.5       59.4 55.0 64.8
At least some college 54.5       70.7 45.0 74.5
Health insurance status
Insured 89.9       69.3 91.0 71.8
Uninsured 10.1       32.6 9.0 42.6
Marital status
Married or one of a couple 61.8       68.9 56.7 71.9
Not married 38.2       60.2 43.3 65.6
Body mass index, kg/m2
<25.0 (Underweight/normal) 31.3       64.5 16.0 68.3
≥25.0 (Overweight/obese) 68.7       66.5 84.0 69.8
Exercised in past 30 days
No 28.5       60.8 39.5 65.4
Yes 71.5       67.6 60.5 71.6
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System (15); NA, not applicable; SE, standard error.
a All values are percentages unless otherwise indicated.
b Defined as having a fecal occult blood test within 1 year, sigmoidoscopy within 5 years and a fecal occult blood test within 3 years, or colonoscopy within 10
years.
(continued on next page)
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(continued)
Table 1. Sociodemographic Characteristics of Adults Aged ≥50, by Diabetes Status and Whether Up-to-Date on Colorectal Cancer
Screening, 2012 BRFSSa
Variable
Adults Aged ≥50 Adults Aged ≥50 With Diabetes
All Up-to-Dateb All Up-to-Dateb
Self-rated general health
Good or better 75.4       66.5 52.0 71.6
Fair or poor 24.6       63.1 48.0 66.7
History of cancer other than colorectal cancer
No 88.7       63.9 86.8 67.6
Yes 11.3       79.2 13.2 79.5
Time since most recent routine checkup
<1 year 78.4       72.2 88.2 71.7
≥1 year 21.6       42.6 11.8 52.4
Comorbidity score
0 80.0       64.5 60.3 68.0
1 16.1       68.6 23.9 70.1
2 3.0       70.1 11.2 72.5
3 0.8       70.7 3.9 74.7
4 0.1       57.9 0.7 55.6
Number of diabetes visits in past year
Mean (SE) NA       NA 3.5 (0.05) 3.5 (0.06)
0-2 NA       NA 31.8 69.7
3-6 NA       NA 47.2 70.6
≥7 NA       NA 21.0 63.4
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System (15); NA, not applicable; SE, standard error.
a All values are percentages unless otherwise indicated.
b Defined as having a fecal occult blood test within 1 year, sigmoidoscopy within 5 years and a fecal occult blood test within 3 years, or colonoscopy within 10
years.
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Table 2. Odds Ratios (95% Confidence Intervals) of Being Up-to-Datea on Colorectal Cancer Screening, Adults Aged ≥50, by Dia-
betes Status, 2012 BRFSS
Variable
Adults Aged ≥50 Adults Aged ≥50 With Diabetes
Univariate Analysis Multivariable Model 1 Univariate Analysis Multivariable Model 2
Diabetes
No 1 [Ref] NA NA NA
Yes 1.22 (1.16–1.27) NA NA NA
Age, y
50–69 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
≥70 1.61 (1.55–1.67) 1.40 (1.34–1.46) 1.38 (1.26–1.52) 1.36 (1.23–1.50)
Sex
Male 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
Female 1.10 (1.06–1.14) 1.12 (1.07–1.16) 1.03 (0.94–1.12) 1.13 (1.02–1.25)
Race
Non-Hispanic white 1 [Ref] 1 [Ref] 1 [Ref] NI
Nonwhite 0.70 (0.67–0.74) 0.89 (0.85–0.94) 0.75 (0.68–0.83) NI
Annual household income, $
<35,000 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
≥35,000 1.79 (1.73–1.86) 1.32 (1.26–1.38) 1.72 (1.57–1.89) 1.36 (1.20–1.54)
Don’t know or refused to answer 1.40 (1.33–1.48) 1.12 (1.05–1.19) 1.21 (1.05–1.39) 1.09 (0.96–1.25)
Education
High school graduate or less 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
At least some college 1.65 (1.59–1.70) 1.44 (1.39–1.50) 1.58 (1.45–1.72) 1.39 (1.26–1.54)
Health insurance status
Insured 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
Uninsured 0.21 (0.20–0.23) 0.40 (0.37–0.43) 0.29 (0.25–0.34) 0.46 (0.38–0.56)
Marital status
Married or one of a couple 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
Not married 0.68 (0.66–0.70) 0.75 (0.72–0.79) 0.74 (0.68–0.81) 0.80 (0.72–0.88)
Body mass index, kg/m2
<25.0 (Underweight/normal) 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
≥25.0 (Overweight/obese) 1.09 (1.05–1.13) 1.12 (1.08–1.17) 1.07 (0.94–1.22) 1.25 (1.09–1.43)
Exercised in past 30 days
No 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
Yes 1.35 (1.30–1.40) 1.25 (1.19–1.30) 1.34 (1.23–1.46) 1.25 (1.13–1.38)
General health
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System (15); NA, not applicable; NI, not included in model as a result of model selection procedure; Ref,
reference.
a Defined as having a fecal occult blood test within 1 year, sigmoidoscopy within 5 years and a fecal occult test within 3 years, or colonoscopy within 10 years.
(continued on next page)
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(continued)
Table 2. Odds Ratios (95% Confidence Intervals) of Being Up-to-Datea on Colorectal Cancer Screening, Adults Aged ≥50, by Dia-
betes Status, 2012 BRFSS
Variable
Adults Aged ≥50 Adults Aged ≥50 With Diabetes
Univariate Analysis Multivariable Model 1 Univariate Analysis Multivariable Model 2
Good or better 1 [Ref] NI 1 [Ref] 1 [Ref]
Fair or poor 0.86 (0.83–0.90) NI 0.79 (0.73–0.87) 0.87 (0.78- 0.97)
History of cancer other than colorectal cancer
No 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
Yes 2.15 (2.04–2.28) 1.85 (1.74–1.97) 1.86 (1.63–2.12) 1.65 (1.41–1.94)
Time since most recent routine checkup
<1 year 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
≥1 year 0.29 (0.27–0.30) NA 0.44 (0.38–0.50) 0.60 (0.50–0.69)
Comorbidity score
0 1 [Ref] 1 [Ref] 1 [Ref] 1 [Ref]
1 1.20 (1.15–1.25) 1.13 (1.08–1.19) 1.10 (1.00–1.22) 1.13 (1.01–1.27)
2 1.29 (1.20–1.38) 1.18 (1.09–1.29) 1.24 (1.07–1.42) 1.34 (1.14–1.57)
3 1.33 (1.14–1.55) 1.25 (1.05–1.49) 1.38 (1.09–1.75) 1.41 (1.08–1.86)
4 0.76 (0.54–1.06) 0.79 (0.52–1.20) 0.59 (0.36–0.95) 1.04 (0.60–1.79)
Number of diabetes visits in past year
0–2 NA NA 1 [Ref] 1 [Ref]
3–6 NA NA 1.05 (0.94–1.16) 1.07 (0.96–1.19)
≥7 NA NA 0.75 (0.66–0.86) 0.89 (0.78–1.02)
Diabetes × time since most recent routine checkup
≥1 Year since most recent checkup:
has diabetes vs does not have
diabetes
NA 1.70 (1.48–1.96) NA NA
Has diabetes: <1 y vs ≥1 y since most
recent checkup
NA 1.90 (1.65–2.19) NA NA
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System (15); NA, not applicable; NI, not included in model as a result of model selection procedure; Ref,
reference.
a Defined as having a fecal occult blood test within 1 year, sigmoidoscopy within 5 years and a fecal occult test within 3 years, or colonoscopy within 10 years.
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